• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国是否存在慢性淋巴细胞白血病(CLL)的流行情况?

Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?

作者信息

Yang Shenmiao, Gale Robert Peter, Shi Hongxia, Liu Yanrong, Lai Yueyun, Lu Jin, Huang Xiaojun

机构信息

Peking University Peoples Hospital, Peking University Institute of Hematology, China.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, SW7 2AZ, UK.

出版信息

Leuk Res. 2018 Oct;73:16-20. doi: 10.1016/j.leukres.2018.08.011. Epub 2018 Aug 22.

DOI:10.1016/j.leukres.2018.08.011
PMID:30176386
Abstract

BACKGROUND

Chronic lymphocytic leukaemia (CLL) is 10- to 20-fold less common in Asians (including Han Chinese) compared with persons of predominately European descent. Why is unknown but seems predominately genetic. We observed an increasing frequency of new cases of CLL at our Haematology Centre beginning 2011 and wondered why.

OBJECTIVE

Determine the cause(s) for this increased frequency.

METHOD

We interrogated the context of CLL diagnosis in 483 consecutive subjects seen at the Institute of Haematology of a large referral hospital in Beijing. 3 cohorts were considered based on why a CBC was done to establish the CLL diagnosis: (1) a CBC-testing situation unrelated to a health condition such as a routine annual health exam or application for employment or medical insurance (termed routine CBC); (2) an unrelated medical condition such as a cold, influenza, heart disease etc. (termed CBC for other disorders); and (3) signs and/or symptoms consistent with CLL such as lymph-adenopathy, hepato- or splenomegaly, fatigue, B-symptoms etc. (termed CBC for possible CLL).

RESULTS

Data regarding context of CLL diagnosis were available for 389 subjects (81%). Proportions of subjects in the 3 cohorts were 44% (95% confidence interval [CI]; 39, 49%), 24% (20, 28%) and 32% (28, 37%). The proportion of subjects whose evaluation of CLL was prompted by an abnormal CBC not for possible CLL (cohorts 1 and 2) increased over the surveillance interval (r = 0.164; P = 0.001) as did median age at diagnosis (r = 0.207; P < 0.001). Age at diagnosis was correlated with probability of CLL being suspected because of an abnormal routine CBC (r = 0.249; P < 0.001); 42% (32, 53%) amongst subjects ≤50 years versus 86% (75, 92%; P < 0.001) among those >70 years. Consistent with this, older subjects were diagnosed at Rai stage-0 with asymptomatic disease compared with younger subjects (P < 0.001).

CONCLUSION

Our data suggest much of the increased frequency of CLL at our centre and likely elsewhere in China predominately reflects ascertainment bias. Other variables may also operate.

摘要

背景

与主要为欧洲血统的人相比,慢性淋巴细胞白血病(CLL)在亚洲人(包括汉族)中的发病率低10至20倍。原因尚不清楚,但似乎主要是遗传因素。我们注意到自2011年起,我院血液科新诊断的CLL病例数不断增加,对此感到疑惑。

目的

确定病例数增加的原因。

方法

我们调查了北京一家大型转诊医院血液研究所连续收治的483例CLL患者的诊断背景。根据进行血常规检查以确诊CLL的原因,将患者分为3组:(1)与健康状况无关的血常规检查情况,如常规年度体检、求职或医疗保险申请(称为常规血常规);(2)其他疾病,如感冒、流感、心脏病等(称为因其他疾病进行的血常规检查);(3)有与CLL相符的体征和/或症状,如淋巴结肿大、肝脾肿大、疲劳、B症状等(称为因可能患有CLL进行的血常规检查)。

结果

389例患者(81%)有CLL诊断背景的数据。3组患者的比例分别为44%(95%置信区间[CI]:39,49%)、24%(20,28%)和32%(28,37%)。在监测期内,因血常规异常(而非可能患有CLL)而促使进行CLL评估的患者比例(第1组和第2组)有所增加(r = 0.164;P = 0.001),诊断时的中位年龄也有所增加(r = 0.207;P < 0.001)。诊断时的年龄与因常规血常规异常而怀疑患有CLL的概率相关(r = 0.249;P < 0.001);≤50岁的患者中这一比例为42%(32,53%),而>70岁的患者中这一比例为86%(75,92%;P < 0.001)。与此一致的是,与年轻患者相比,老年患者多在Rai 0期被诊断为无症状疾病(P < 0.001)。

结论

我们的数据表明,我院CLL病例数增加,在中国其他地方可能也是如此,这主要反映了确诊偏倚。其他因素可能也有作用。

相似文献

1
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?中国是否存在慢性淋巴细胞白血病(CLL)的流行情况?
Leuk Res. 2018 Oct;73:16-20. doi: 10.1016/j.leukres.2018.08.011. Epub 2018 Aug 22.
2
The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?慢性淋巴细胞白血病(CLL)之谜:为什么亚洲人没有这种病?这对病因学、发病机制和生物学有何启示?
Blood Rev. 2015 May;29(3):205-13. doi: 10.1016/j.blre.2014.12.001. Epub 2014 Dec 13.
3
Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis.明尼苏达州奥尔姆斯特德县1935年至1989年慢性淋巴细胞白血病的发病率,重点关注诊断时初始阶段的变化。
Mayo Clin Proc. 1994 Apr;69(4):323-8. doi: 10.1016/s0025-6196(12)62215-0.
4
[Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].[2003年至2013年冰岛的慢性淋巴细胞白血病:发病率、临床表现及诊断]
Laeknabladid. 2016 Apr;102(4):171-7. doi: 10.17992/lbl.2016.04.74.
5
The clinical and epidemiological burden of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的临床及流行病学负担
Eur J Cancer Care (Engl). 2004 Jul;13(3):279-87. doi: 10.1111/j.1365-2354.2004.00489.x.
6
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.美国慢性淋巴细胞白血病及其变异在临床表现和结局方面的种族差异。
Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):498-506. doi: 10.1016/j.clml.2011.07.002. Epub 2011 Sep 1.
7
Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).慢性淋巴细胞白血病患者的发病率及医疗资源利用趋势:来自英国临床实践研究数据链(CPRD)的见解
Ann Hematol. 2015 Mar;94(3):421-9. doi: 10.1007/s00277-014-2217-7. Epub 2014 Sep 16.
8
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.慢性淋巴细胞白血病向里斯特综合征转化的生物学和临床危险因素。
Br J Haematol. 2008 Jun;142(2):202-15. doi: 10.1111/j.1365-2141.2008.07166.x. Epub 2008 May 19.
9
Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中晚期白血病和皮肤癌肿瘤分期与皮肤癌不良预后相关。
JAMA Dermatol. 2014 Mar;150(3):280-7. doi: 10.1001/jamadermatol.2013.6249.
10
Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?荷兰癌症幸存者中慢性淋巴细胞白血病风险增加:是检出增加、因果因素还是两者兼有?
Ann Hematol. 2014 Jan;93(1):157-62. doi: 10.1007/s00277-013-1929-4. Epub 2013 Oct 25.

引用本文的文献

1
Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets.环状RNA在恶性淋巴增殖性疾病中的分子意义:发病机制及新型生物标志物或治疗靶点
Am J Cancer Res. 2024 Sep 25;14(9):4633-4651. doi: 10.62347/KMWB5164. eCollection 2024.
2
-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients.- 突变型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤作为一个独特的分子亚组与中国患者的非典型免疫表型相关。
J Clin Med. 2023 Apr 3;12(7):2667. doi: 10.3390/jcm12072667.
3
CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis.
环状RNA RIC8B通过miR199b-5p/脂蛋白脂肪酶轴调控慢性淋巴细胞白血病的脂质代谢。
Exp Hematol Oncol. 2022 Sep 5;11(1):51. doi: 10.1186/s40164-022-00302-0.
4
IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.中国慢性淋巴细胞白血病患者的IGH易位:临床病理特征与基因图谱
Front Oncol. 2022 Jun 2;12:858523. doi: 10.3389/fonc.2022.858523. eCollection 2022.
5
BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.BCL-2 表达通过增强调节性 T 细胞分化和细胞毒性 T 细胞耗竭促进慢性淋巴细胞白血病中的免疫抑制。
Mol Cancer. 2022 Feb 22;21(1):59. doi: 10.1186/s12943-022-01516-w.
6
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea.韩国慢性淋巴细胞白血病患者的多中心回顾性分析。
Blood Res. 2021 Dec 31;56(4):243-251. doi: 10.5045/br.2021.2021102.
7
New kid on the block: C-reactive protein-to-albumin ratio as a new prognostic marker for chronic lymphocytic leukemia: Comment on "C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases".领域新成员:C反应蛋白与白蛋白比值作为慢性淋巴细胞白血病的新预后标志物:对《C反应蛋白与白蛋白比值是新诊断慢性淋巴细胞白血病的独立不良预后因素:322例临床分析》的评论
Transl Oncol. 2021 Aug;14(8):101098. doi: 10.1016/j.tranon.2021.101098.
8
Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH Rearrangements: Report of Three Chinese Cases and Literature Review.病例报告:伴有罕见的涉及IGH重排的t(14;19)(q32;q13)易位的慢性淋巴细胞白血病:三例中国病例报告及文献综述
Front Oncol. 2020 Nov 19;10:594732. doi: 10.3389/fonc.2020.594732. eCollection 2020.
9
Ethnic and geographic diversity of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的种族和地域多样性。
Leukemia. 2021 Feb;35(2):433-439. doi: 10.1038/s41375-020-01057-5. Epub 2020 Oct 19.
10
Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study.基于医院人群的淋巴细胞增多症患者的单克隆 B 淋巴细胞扩增的筛查:一项观察性队列研究。
BMJ Open. 2020 Sep 15;10(9):e036006. doi: 10.1136/bmjopen-2019-036006.